Investigational Site Number : 6160004

Gdynia, Pomeranian Voivodeship 81-519

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer — Stopped early